Results 171 to 180 of about 95,860 (291)

Cyclosporine Toxicity [PDF]

American Journal of Kidney Diseases, 2000
openaire   +2 more sources

Drug-Induced Gingival Overgrowth Associated With Cyclosporine Therapy: A Case Report of a 23-Year Periodontal Follow-Up in a Heart Transplant Recipient. [PDF]

Cureus
Valente P, Sbrenna L, Valente F, Sbrenna A, Mascolo A.   +4 more
europepmc   +1 more source

Molecular Changes Induced by Carbon Dioxide Laser in Hailey‐Hailey Disease: A Potential Mechanism Underlying Treatment Efficacy

International Journal of Dermatology, EarlyView.
ABSTRACT Introduction Hailey‐Hailey disease (HHD) is a rare genodermatosis caused by mutations in the ATP2C1 gene that codes for SPCA1, a calcium transporter in the epidermis. HHD impairs quality of life, and no curative treatment exists. Methods To confirm the efficacy and safety of CO2 laser in HHD, we conducted a randomized, prospective, controlled ...
Javier Antoñanzas, Agustín España, Ana Gorostidi, Ana Patiño‐García, Marcos J. Araúzo‐Bravo, Daniela Gerovska, Rafael Salido‐Vallejo, Leyre Aguado‐Gil   +7 more
wiley   +1 more source

Efficacy and safety of cyclosporine a combined with acitretin in moderate-to-severe plaque psoriasis: a randomized controlled trial. [PDF]

Front Med (Lausanne)
Xu K, Yuan P, Jia S, Gong C, Hu Q, Sun J, Zhu C, Wang J, Xu S.   +8 more
europepmc   +1 more source

Cyclosporine/ketoconazole reduces treatment costs for nephrotic syndrome

, 2013
Arpana Iyengar, Nivedita Kamath, K Phadke, Martin Bitzan   +3 more
openalex   +1 more source

Efficacy and Safety of Conventional and Biologic Therapies in Prurigo Nodularis: A Systematic Review and Meta‐Analysis

International Journal of Dermatology, EarlyView.
ABSTRACT Prurigo nodularis (PN) is a chronic, intensely pruritic skin disorder characterized by hyperkeratotic nodules and a debilitating itch–scratch cycle. Conventional therapies have limited efficacy and safety issues, while biologics have recently emerged as a promising alternative.
Andrea Lancz, Fanni Adél Meznerics, Renáta Árok, Anna Sára Lengyel, Bence Szabó, Péter Hegyi, Norbert Kiss, András Bánvölgyi   +7 more
wiley   +1 more source

Efficacy and safety of eltrombopag in combination with cyclosporine A for the treatment of adult refractory primary immune thrombocytopenia: a phase II, multicenter, single-arm, prospective study. [PDF]

Clin Exp Med
Huang C, Jin J, Lai J, Zhen W, Fan C, Fu G, Wu H, Yu W, Jiang H, Wang X, Chen H, Qin J, Cao L.   +12 more
europepmc   +1 more source

One year follow-up of the cardio-metabolic profile evolution in renal transplant patients treated with alemtuzumab, cyclosporine, and steroids in a reference hospital in Colombia

, 2015
JF Nieto-Ríos, Narly Viviana Gómez, Lina María Serna-­Higuita, Catalina Ocampo-­Kohn, Arbey Aristizábal­-Alzate, Harry Abadía-Guzmán, Carlos Enrique Yepes Delgado, Gustavo Adolfo Zuluaga-­Valencia, G Zuluaga-Valencia   +8 more
openalex   +2 more sources

Minimal Disease Activity as A New Therapeutic Target in Atopic Dermatitis: A 5‐Year Real‐Life Experience With Dupilumab

International Journal of Dermatology, EarlyView.
ABSTRACT Background Atopic dermatitis (AD) is a chronic inflammatory skin disease with significant physical and psychosocial burden. Dupilumab, a monoclonal antibody targeting IL‐4Rα, has proven to be effective for moderate‐to‐severe AD, but long‐term real‐world data remain limited.
Francesco Leo, Luca Mastorino, Luca Cangialosi, Davide Favre, Chiara Anna Fiasconaro, Yingying Liao, Federico Goso, Niccolò Siliquini, Giovanni Cavaliere, Pietro Quaglino, Simone Ribero, Michela Ortoncelli   +11 more
wiley   +1 more source

CHASERR-CHD2 dynamics in T cell quiescence and its modulation by cyclosporine. [PDF]

Front Immunol
Budkina A, Zubritskiy A, Marakulina D, Loguinova MY, Sergeev NA, Medvedeva YA.   +5 more
europepmc   +1 more source